MYC and metabolic syndrome: The common target PPI network analysis showed that the key targets of the SZHP in the treatment of dyslipidemia included CCND1, CASP3, HIF1A, ESR1, ERBB2, MYC, PTEN, TP53, AKT1, and EGFR.